International Journal of Epidemiology, Vol 28, 1156-1160, Copyright © 1999 by International Epidemiological Association
LA Fonseca, AL Reingold, JR Casseb, LF Brigido and AJ Duarte
BACKGROUND: In spite of the high incidence of AIDS in Brazil, few studies
have tried to evaluate the prognosis of asymptomatic HIV seropositive
Brazilian patients. METHODS: A hospital outpatient facility-based cohort of
HIV seropositive asymptomatic subjects was followed to determine their
probability of remaining AIDS-free at 2 and 4 years of follow-up, as well
as the one-year estimated cumulative probability of survival for the AIDS
incident cases. The cohort was made up of all asymptomatic HIV seropositive
subjects referred to the Immunology Branch of a large university hospital
in Sao Paulo, Brazil, between 1985 and June 1997. RESULTS: The cumulative
probability of remaining free from AIDS was 79% (+/- 3.7% SE) at 2 years,
and 64.4% (+/- 5.1% SE) at 4 years after first known positive anti-HIV
serology. Women had a marginally significant better probability of
remaining AIDS- free after both 2 and 4 years of known seropositivity, as
compared with men. There were no significant differences in the prognosis
of the infection by age; the only single parameter associated with better
prognosis was an initial CD4+ count > or =350/microl. The probability of
survival one year after the diagnosis of AIDS was 78%, and the 50%
estimated probability of survival was 19 months. Older patients (aged >
or =35 years) had a better prognosis, as suggested by their longer survival
estimates (P = 0.06). CONCLUSIONS: The probability of survival with AIDS
observed in this study was higher than in the few previously published
estimates for Brazil. However, since the time frame was so wide, it may not
be entirely comparable with earlier studies. Some likely explanations for
this possibly better prognosis could include more efficient prophylaxis for
opportunistic diseases, as well as an increase in the availability of
anti-retroviral drugs. The 8% incidence of AIDS at 2 years observed in this
study for those individuals whose initial CD4+ count was > or =350/ml
was close to that found in a large international epidemiological study of
seroconverters.
AIDS incidence and survival in a hospital-based cohort of asymptomatic HIV seropositive patients in Sao Paulo, Brazil
University of California, Berkeley, School of Public Health, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?